BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16924243)

  • 1. Human tumor suppressor p14ARF negatively regulates rRNA transcription and inhibits UBF1 transcription factor phosphorylation.
    Ayrault O; Andrique L; Fauvin D; Eymin B; Gazzeri S; Séité P
    Oncogene; 2006 Dec; 25(58):7577-86. PubMed ID: 16924243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the transcriptional factor E2F1 in the regulation of the rRNA promoter.
    Ayrault O; Andrique L; Séité P
    Exp Cell Res; 2006 Apr; 312(7):1185-93. PubMed ID: 16510138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The negative regulation of ribosome biogenesis: a new Arf-dependent pathway controlling cell proliferation?].
    Ayrault O; Andrique L; Larsen CJ; Séité P
    Med Sci (Paris); 2006 May; 22(5):519-24. PubMed ID: 16687121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Arf tumor suppressor specifically interacts with chromatin containing the promoter of rRNA genes.
    Ayrault O; Andrique L; Larsen CJ; Seite P
    Oncogene; 2004 Oct; 23(49):8097-104. PubMed ID: 15361825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myc and E2F1 induce p53 through p14ARF-independent mechanisms in human fibroblasts.
    Lindström MS; Wiman KG
    Oncogene; 2003 Aug; 22(32):4993-5005. PubMed ID: 12902982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p14ARF interacts with E2F factors to form p14ARF-E2F/partner-DNA complexes repressing E2F-dependent transcription.
    Zhang HJ; Li WJ; Gu YY; Li SY; An GS; Ni JH; Jia HT
    J Cell Biochem; 2010 Mar; 109(4):693-701. PubMed ID: 20082327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus 16 oncoprotein E7 stimulates UBF1-mediated rDNA gene transcription, inhibiting a p53-independent activity of p14ARF.
    Dichamp I; Séité P; Agius G; Barbarin A; Beby-Defaux A
    PLoS One; 2014; 9(5):e96136. PubMed ID: 24798431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 8-Chloro-adenosine-induced E2F1 promotes p14ARF gene activation in H1299 cells through displacing Sp1 from multiple overlapping E2F1/Sp1 sites.
    Zhang HJ; Li WJ; Yang SY; Li SY; Ni JH; Jia HT
    J Cell Biochem; 2009 Feb; 106(3):464-72. PubMed ID: 19115249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleolar localization of aprataxin is dependent on interaction with nucleolin and on active ribosomal DNA transcription.
    Becherel OJ; Gueven N; Birrell GW; Schreiber V; Suraweera A; Jakob B; Taucher-Scholz G; Lavin MF
    Hum Mol Genet; 2006 Jul; 15(14):2239-49. PubMed ID: 16777843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo analysis of the interaction between 5.8S rRNA and ARF protein reveal a new difference between murine p19ARF and human p14ARF.
    Andrique L; Ayrault O; Larsen CJ; Séité P
    Oncogene; 2005 Apr; 24(15):2580-4. PubMed ID: 15735732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitination of, and sumoylation by, the Arf tumor suppressor.
    den Besten W; Kuo ML; Tago K; Williams RT; Sherr CJ
    Isr Med Assoc J; 2006 Apr; 8(4):249-51. PubMed ID: 16671360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ARF antagonizes the ability of Miz-1 to inhibit p53-mediated transactivation.
    Miao L; Song Z; Jin L; Zhu YM; Wen LP; Wu M
    Oncogene; 2010 Feb; 29(5):711-22. PubMed ID: 19901969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual regulation of upstream binding factor 1 levels by IRS-1 and ERKs in IGF-1-receptor signaling.
    Sun H; Tu X; Liu M; Baserga R
    J Cell Physiol; 2007 Sep; 212(3):780-6. PubMed ID: 17443674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ARF tumour suppressor.
    Gallagher SJ; Kefford RF; Rizos H
    Int J Biochem Cell Biol; 2006; 38(10):1637-41. PubMed ID: 16600663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AP-1 dimers regulate transcription of the p14/p19ARF tumor suppressor gene.
    Ameyar-Zazoua M; Wisniewska MB; Bakiri L; Wagner EF; Yaniv M; Weitzman JB
    Oncogene; 2005 Mar; 24(14):2298-306. PubMed ID: 15688012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delocalization and destabilization of the Arf tumor suppressor by the leukemia-associated NPM mutant.
    Colombo E; Martinelli P; Zamponi R; Shing DC; Bonetti P; Luzi L; Volorio S; Bernard L; Pruneri G; Alcalay M; Pelicci PG
    Cancer Res; 2006 Mar; 66(6):3044-50. PubMed ID: 16540653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2F1 suppresses skin carcinogenesis via the ARF-p53 pathway.
    Russell JL; Weaks RL; Berton TR; Johnson DG
    Oncogene; 2006 Feb; 25(6):867-76. PubMed ID: 16205640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of p14ARF by E2F1 contributes to 8-chloro-adenosine-induced apoptosis in human lung cancer H1299 cells.
    Li WJ; Gu YY; Zhang HJ; Zhou J; Jia HT
    Chemotherapy; 2009; 55(5):335-43. PubMed ID: 19641316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p14ARF interacts with N-Myc and inhibits its transcriptional activity.
    Amente S; Gargano B; Diolaiti D; Della Valle G; Lania L; Majello B
    FEBS Lett; 2007 Mar; 581(5):821-5. PubMed ID: 17289033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p14ARF regulates E2F-1 ubiquitination and degradation via a p53-dependent mechanism.
    Rizos H; Scurr LL; Irvine M; Alling NJ; Kefford RF
    Cell Cycle; 2007 Jul; 6(14):1741-7. PubMed ID: 17630509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.